GENELUX Corp (GNLX) Corporate Subsidiaries
GENELUX Corp (GNLX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: GNLX
CIK: 1231457
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Weinberg & Company, P.A.
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerJohn Lucas
Audit LocationLos Angeles, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-02 | 2026-08-31 | 4 | 0001493152-26-041285 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | 4 | 0001493152-26-041284 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | 4 | 0001493152-26-041283 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001493152-26-037667 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-08-04 | 4 | 0001493152-26-036077 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-08-04 | 4 | 0001493152-26-036076 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-08-04 | 4 | 0001493152-26-036075 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-07-01 | 4 | 0001493152-26-031927 | View SEC Doc Filr Page |
| 144 | 2026-07-01 | — | 144 Filing | 0001950047-26-006798 | View SEC Doc Filr Page |
| 8-K | 2026-06-22 | 2026-06-16 | 8-K | 0001493152-26-029607 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | 4 | 0001493152-26-029421 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | 4 | 0001493152-26-029420 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | 4 | 0001493152-26-029419 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | 4 | 0001493152-26-029418 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | 4 | 0001493152-26-029417 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | 4 | 0001493152-26-029416 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | 4 | 0001493152-26-029415 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | 4 | 0001493152-26-029414 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | 4 | 0001493152-26-029413 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-03 | 4 | 0001493152-26-027348 | View SEC Doc Filr Page |
| 4 | 2026-06-02 | 2026-06-01 | 4 | 0001493152-26-026930 | View SEC Doc Filr Page |
| 144 | 2026-06-01 | — | 144 Filing | 0001950047-26-005413 | View SEC Doc Filr Page |
| 4 | 2026-05-12 | 2026-05-11 | 4 | 0001493152-26-022567 | View SEC Doc Filr Page |
| 4 | 2026-05-12 | 2026-05-11 | 4 | 0001493152-26-022568 | View SEC Doc Filr Page |
| 4 | 2026-05-12 | 2026-05-11 | 4 | 0001493152-26-022566 | View SEC Doc Filr Page |